The injectable drug market is evaluated to be sized at US$ 5,97,980.6 million in 2024. During the period from 2024 to 2034, the market is expected to progress at a solid clip, registering a CAGR of 5.8%. By 2034, the injectable drug market is anticipated to have reached a value of US$ 9,91,631.3 million.
Global Injectable Drug Market Overview
| Attributes | Details |
|---|---|
| Injectable Drug Market Value for 2024 | US$ 5,97,980.6 million |
| Projected Market Value for 2034 | US$ 9,91,631.3 million |
| Value-based CAGR of Market for 2024 to 2034 | 5.8% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Apart from the injectable drug market, an in-depth analysis has been done on two other related markets. The markets by name are the injectable drug delivery market and the injection pen market.
More people getting comfortable with injecting medication at home are seeing instances of injectable drug delivery increase. The development of the injectable drug market helps the demand prospects of the injectable drug delivery market.
Diabetes cases growing, especially in Asian countries, is necessitating the use of injection pens. Technological advancements in the pen are also set to sweeten the deal for market players.
Injectable Drug Market:
| Attributes | Injectable Drug Market |
|---|---|
| Value-based CAGR (2024 to 2034) | 5.8% |
| Projected Market Value (2034) | US$ 9,91,631.3 million |
| Market Trends |
|
| Restraint | Patient fear of needles |
| Growth Factors |
|
Injectable Drug Delivery Market:
| Attributes | Injectable Drug Delivery Market |
|---|---|
| Value-based CAGR (2024 to 2034) | 8.9% |
| Market Trend | Minimally invasive procedures becoming more commonplace |
| Restraint | High cost associated with injectable drugs |
| Growth Factor | Increase in patients comfortable with taking injections at home |
Injection Pen Market:
| Attributes | Injection Pen Market |
|---|---|
| Value-based CAGR (2024 to 2034) | 14.2% |
| Market Trend | Technological advancements like precise dosage administration |
| Restraint | Inadequate training and guidance limiting number of users |
| Growth Factor | Growing cases of diabetes |
Principal Consultant
Monoclonal antibodies stand atop the pile in the product type segment. Intravenous (IV) injections remain the predominant mode of administration.
Monoclonal antibodies are expected to account for 25.2% of the market share in 2024. Some of the factors influencing the increase in demand for monoclonal antibodies are:
| Attributes | Details |
|---|---|
| Top Product Type | Monoclonal Antibody |
| Market Share (2024) | 10.8% |
Intravenous (IV) injections are anticipated to account for 48.3% of the market share in 2024. Some of the reasons for the progress of intravenous (IV) injections are:
| Attributes | Details |
|---|---|
| Top Route of Administration | Intravenous (IV) injections |
| Market Share (2024) | 48.3% |
Problems like the aging population and the rise in mental health problems are seeing the healthcare sector develop in Europe. The rise in patients is invariably leading to greater demand for injectable drugs.
The Europe Medicines Agency (EMA) approving injectable drugs for marketing and distribution at a fair rate is propelling the market in Europe. Governments in Europe striving to make healthcare affordable in Europe is also helping the market’s development.
| Countries | CAGR (2024 to 2034) |
|---|---|
| Spain | 4.0% |
| United Kingdom | 3.0% |
| Italy | 3.3% |
| France | 3.4% |
| Germany | 2.5% |
The CAGR of the market for the forecast period in Spain is anticipated to be 4.0%. Some of the factors influencing the growth of the market in the country are:
The market is expected to register a CAGR of 3.0% in the United Kingdom through 2034. Some of the factors responsible for the growth of the market are:
The market is expected to progress at a CAGR of 3.4% in France for the forecast period. Some factors influencing the progress are:
The market is expected to progress at a CAGR of 3.3% in Italy throughout the forecast period. Some factors influencing the progress are:
The market is expected to progress at a CAGR of 2.5% in Germany. Some factors influencing the progress are:
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The injectable drug market is moderately fragmented. Multinational companies are focusing on expanding production, while small-scale companies are looking for investments to remain competitive.
Pfizer Inc.’s personalized approach towards patients is seeing the company develop targeted injectable drugs. Other companies in the market are establishing partnerships between themselves to develop and advertise new products.
Recent Developments in the Injectable Drug Market
The size of the injectable drug market is estimated to be US$ 5,97,980.6 million in 2024.
The injectable drug market is expected to increase at a CAGR of 5.8% over the forecast period.
The injectable drug market is expected to register a CAGR of 3.0% in the United Kingdom over the period from 2024 to 2034.
The injectable drug market is forecasted to reach a size of US$ 9,91,631.3 million by 2034.
Use of biotechnology for developing new drugs and the rising importance of vaccines are two of the trends in the injectable drug industry.
Pfizer Inc., Teva Pharmaceutical Industries Ltd., Sanofi S.A., and Sun Pharmaceutical Industries Ltd. are some of the prominent companies in the injectable drug market.
Monoclonal antibodies are the top product type in the injectable drug market, with an estimated market share of 10.8% in 2024.
The injectable drug market is expected to register a CAGR of 2.5% in Germany over the period from 2024 to 2034.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Manufacturer 3.5.1.2. Mid-Level Participants (Traders) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034 4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2019 to 2023 4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2024 to 2034 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product, 2019 to 2023 5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product, 2024 to 2034 5.3.1. Monoclonal Antibodies 5.3.2. Immunoglobulin 5.3.3. Cytokines 5.3.4. Insulin 5.3.5. Peptide Hormones 5.3.6. Blood Factors 5.3.7. Peptide Antibiotics 5.3.8. Vaccines 5.3.9. Small Molecule Antibiotics 5.3.10. Chemotherapy Agents 5.3.11. Others 5.4. Y-o-Y Growth Trend Analysis By Product, 2019 to 2023 5.5. Absolute $ Opportunity Analysis By Product, 2024 to 2034 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Application, 2019 to 2023 6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Application, 2024 to 2034 6.3.1. Oncology 6.3.2. Infectious Diseases 6.3.3. Diabetes 6.3.4. Blood disorders 6.3.5. Hormonal Disorders 6.3.6. Musculoskeletal Disorders 6.3.7. CNS Diseases 6.3.8. Pain Management 6.3.9. Cardiovascular Diseases 6.4. Y-o-Y Growth Trend Analysis By Application, 2019 to 2023 6.5. Absolute $ Opportunity Analysis By Application, 2024 to 2034 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Molecule Type 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Molecule Type, 2019 to 2023 7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Molecule Type, 2024 to 2034 7.3.1. Small Molecules 7.3.2. Large Molecules 7.4. Y-o-Y Growth Trend Analysis By Molecule Type, 2019 to 2023 7.5. Absolute $ Opportunity Analysis By Molecule Type, 2024 to 2034 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Route of Administration 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Route of Administration, 2019 to 2023 8.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Route of Administration, 2024 to 2034 8.3.1. Intravenous (IV) 8.3.2. Intramuscular (IM) 8.3.3. Subcutaneous (SC) 8.4. Y-o-Y Growth Trend Analysis By Route of Administration, 2019 to 2023 8.5. Absolute $ Opportunity Analysis By Route of Administration, 2024 to 2034 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel 9.1. Introduction / Key Findings 9.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Distribution Channel, 2019 to 2023 9.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Distribution Channel, 2024 to 2034 9.3.1. Hospital Pharmacies 9.3.2. Retail Pharmacies 9.3.3. Drug Stores 9.3.4. Online Pharmacies 9.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2019 to 2023 9.5. Absolute $ Opportunity Analysis By Distribution Channel, 2024 to 2034 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 10.1. Introduction 10.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2019 to 2023 10.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2024 to 2034 10.3.1. North America 10.3.2. Latin America 10.3.3. Western Europe 10.3.4. Eastern Europe 10.3.5. South Asia and Pacific 10.3.6. East Asia 10.3.7. Middle East and Africa 10.4. Market Attractiveness Analysis By Region 11. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 11.2.1. By Country 11.2.1.1. USA 11.2.1.2. Canada 11.2.2. By Product 11.2.3. By Application 11.2.4. By Molecule Type 11.2.5. By Route of Administration 11.2.6. By Distribution Channel 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product 11.3.3. By Application 11.3.4. By Molecule Type 11.3.5. By Route of Administration 11.3.6. By Distribution Channel 11.4. Key Takeaways 12. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 12.2.1. By Country 12.2.1.1. Brazil 12.2.1.2. Mexico 12.2.1.3. Rest of Latin America 12.2.2. By Product 12.2.3. By Application 12.2.4. By Molecule Type 12.2.5. By Route of Administration 12.2.6. By Distribution Channel 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product 12.3.3. By Application 12.3.4. By Molecule Type 12.3.5. By Route of Administration 12.3.6. By Distribution Channel 12.4. Key Takeaways 13. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 13.2.1. By Country 13.2.1.1. Germany 13.2.1.2. UK 13.2.1.3. France 13.2.1.4. Spain 13.2.1.5. Italy 13.2.1.6. Rest of Western Europe 13.2.2. By Product 13.2.3. By Application 13.2.4. By Molecule Type 13.2.5. By Route of Administration 13.2.6. By Distribution Channel 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product 13.3.3. By Application 13.3.4. By Molecule Type 13.3.5. By Route of Administration 13.3.6. By Distribution Channel 13.4. Key Takeaways 14. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 14.2.1. By Country 14.2.1.1. Poland 14.2.1.2. Russia 14.2.1.3. Czech Republic 14.2.1.4. Romania 14.2.1.5. Rest of Eastern Europe 14.2.2. By Product 14.2.3. By Application 14.2.4. By Molecule Type 14.2.5. By Route of Administration 14.2.6. By Distribution Channel 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product 14.3.3. By Application 14.3.4. By Molecule Type 14.3.5. By Route of Administration 14.3.6. By Distribution Channel 14.4. Key Takeaways 15. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 15.2.1. By Country 15.2.1.1. India 15.2.1.2. Bangladesh 15.2.1.3. Australia 15.2.1.4. New Zealand 15.2.1.5. Rest of South Asia and Pacific 15.2.2. By Product 15.2.3. By Application 15.2.4. By Molecule Type 15.2.5. By Route of Administration 15.2.6. By Distribution Channel 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Product 15.3.3. By Application 15.3.4. By Molecule Type 15.3.5. By Route of Administration 15.3.6. By Distribution Channel 15.4. Key Takeaways 16. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 16.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 16.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 16.2.1. By Country 16.2.1.1. China 16.2.1.2. Japan 16.2.1.3. South Korea 16.2.2. By Product 16.2.3. By Application 16.2.4. By Molecule Type 16.2.5. By Route of Administration 16.2.6. By Distribution Channel 16.3. Market Attractiveness Analysis 16.3.1. By Country 16.3.2. By Product 16.3.3. By Application 16.3.4. By Molecule Type 16.3.5. By Route of Administration 16.3.6. By Distribution Channel 16.4. Key Takeaways 17. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 17.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 17.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 17.2.1. By Country 17.2.1.1. GCC Countries 17.2.1.2. South Africa 17.2.1.3. Israel 17.2.1.4. Rest of MEA 17.2.2. By Product 17.2.3. By Application 17.2.4. By Molecule Type 17.2.5. By Route of Administration 17.2.6. By Distribution Channel 17.3. Market Attractiveness Analysis 17.3.1. By Country 17.3.2. By Product 17.3.3. By Application 17.3.4. By Molecule Type 17.3.5. By Route of Administration 17.3.6. By Distribution Channel 17.4. Key Takeaways 18. Key Countries Market Analysis 18.1. USA 18.1.1. Pricing Analysis 18.1.2. Market Share Analysis, 2023 18.1.2.1. By Product 18.1.2.2. By Application 18.1.2.3. By Molecule Type 18.1.2.4. By Route of Administration 18.1.2.5. By Distribution Channel 18.2. Canada 18.2.1. Pricing Analysis 18.2.2. Market Share Analysis, 2023 18.2.2.1. By Product 18.2.2.2. By Application 18.2.2.3. By Molecule Type 18.2.2.4. By Route of Administration 18.2.2.5. By Distribution Channel 18.3. Brazil 18.3.1. Pricing Analysis 18.3.2. Market Share Analysis, 2023 18.3.2.1. By Product 18.3.2.2. By Application 18.3.2.3. By Molecule Type 18.3.2.4. By Route of Administration 18.3.2.5. By Distribution Channel 18.4. Mexico 18.4.1. Pricing Analysis 18.4.2. Market Share Analysis, 2023 18.4.2.1. By Product 18.4.2.2. By Application 18.4.2.3. By Molecule Type 18.4.2.4. By Route of Administration 18.4.2.5. By Distribution Channel 18.5. Germany 18.5.1. Pricing Analysis 18.5.2. Market Share Analysis, 2023 18.5.2.1. By Product 18.5.2.2. By Application 18.5.2.3. By Molecule Type 18.5.2.4. By Route of Administration 18.5.2.5. By Distribution Channel 18.6. UK 18.6.1. Pricing Analysis 18.6.2. Market Share Analysis, 2023 18.6.2.1. By Product 18.6.2.2. By Application 18.6.2.3. By Molecule Type 18.6.2.4. By Route of Administration 18.6.2.5. By Distribution Channel 18.7. France 18.7.1. Pricing Analysis 18.7.2. Market Share Analysis, 2023 18.7.2.1. By Product 18.7.2.2. By Application 18.7.2.3. By Molecule Type 18.7.2.4. By Route of Administration 18.7.2.5. By Distribution Channel 18.8. Spain 18.8.1. Pricing Analysis 18.8.2. Market Share Analysis, 2023 18.8.2.1. By Product 18.8.2.2. By Application 18.8.2.3. By Molecule Type 18.8.2.4. By Route of Administration 18.8.2.5. By Distribution Channel 18.9. Italy 18.9.1. Pricing Analysis 18.9.2. Market Share Analysis, 2023 18.9.2.1. By Product 18.9.2.2. By Application 18.9.2.3. By Molecule Type 18.9.2.4. By Route of Administration 18.9.2.5. By Distribution Channel 18.10. Poland 18.10.1. Pricing Analysis 18.10.2. Market Share Analysis, 2023 18.10.2.1. By Product 18.10.2.2. By Application 18.10.2.3. By Molecule Type 18.10.2.4. By Route of Administration 18.10.2.5. By Distribution Channel 18.11. Russia 18.11.1. Pricing Analysis 18.11.2. Market Share Analysis, 2023 18.11.2.1. By Product 18.11.2.2. By Application 18.11.2.3. By Molecule Type 18.11.2.4. By Route of Administration 18.11.2.5. By Distribution Channel 18.12. Czech Republic 18.12.1. Pricing Analysis 18.12.2. Market Share Analysis, 2023 18.12.2.1. By Product 18.12.2.2. By Application 18.12.2.3. By Molecule Type 18.12.2.4. By Route of Administration 18.12.2.5. By Distribution Channel 18.13. Romania 18.13.1. Pricing Analysis 18.13.2. Market Share Analysis, 2023 18.13.2.1. By Product 18.13.2.2. By Application 18.13.2.3. By Molecule Type 18.13.2.4. By Route of Administration 18.13.2.5. By Distribution Channel 18.14. India 18.14.1. Pricing Analysis 18.14.2. Market Share Analysis, 2023 18.14.2.1. By Product 18.14.2.2. By Application 18.14.2.3. By Molecule Type 18.14.2.4. By Route of Administration 18.14.2.5. By Distribution Channel 18.15. Bangladesh 18.15.1. Pricing Analysis 18.15.2. Market Share Analysis, 2023 18.15.2.1. By Product 18.15.2.2. By Application 18.15.2.3. By Molecule Type 18.15.2.4. By Route of Administration 18.15.2.5. By Distribution Channel 18.16. Australia 18.16.1. Pricing Analysis 18.16.2. Market Share Analysis, 2023 18.16.2.1. By Product 18.16.2.2. By Application 18.16.2.3. By Molecule Type 18.16.2.4. By Route of Administration 18.16.2.5. By Distribution Channel 18.17. New Zealand 18.17.1. Pricing Analysis 18.17.2. Market Share Analysis, 2023 18.17.2.1. By Product 18.17.2.2. By Application 18.17.2.3. By Molecule Type 18.17.2.4. By Route of Administration 18.17.2.5. By Distribution Channel 18.18. China 18.18.1. Pricing Analysis 18.18.2. Market Share Analysis, 2023 18.18.2.1. By Product 18.18.2.2. By Application 18.18.2.3. By Molecule Type 18.18.2.4. By Route of Administration 18.18.2.5. By Distribution Channel 18.19. Japan 18.19.1. Pricing Analysis 18.19.2. Market Share Analysis, 2023 18.19.2.1. By Product 18.19.2.2. By Application 18.19.2.3. By Molecule Type 18.19.2.4. By Route of Administration 18.19.2.5. By Distribution Channel 18.20. South Korea 18.20.1. Pricing Analysis 18.20.2. Market Share Analysis, 2023 18.20.2.1. By Product 18.20.2.2. By Application 18.20.2.3. By Molecule Type 18.20.2.4. By Route of Administration 18.20.2.5. By Distribution Channel 18.21. GCC Countries 18.21.1. Pricing Analysis 18.21.2. Market Share Analysis, 2023 18.21.2.1. By Product 18.21.2.2. By Application 18.21.2.3. By Molecule Type 18.21.2.4. By Route of Administration 18.21.2.5. By Distribution Channel 18.22. South Africa 18.22.1. Pricing Analysis 18.22.2. Market Share Analysis, 2023 18.22.2.1. By Product 18.22.2.2. By Application 18.22.2.3. By Molecule Type 18.22.2.4. By Route of Administration 18.22.2.5. By Distribution Channel 18.23. Israel 18.23.1. Pricing Analysis 18.23.2. Market Share Analysis, 2023 18.23.2.1. By Product 18.23.2.2. By Application 18.23.2.3. By Molecule Type 18.23.2.4. By Route of Administration 18.23.2.5. By Distribution Channel 19. Market Structure Analysis 19.1. Competition Dashboard 19.2. Competition Benchmarking 19.3. Market Share Analysis of Top Players 19.3.1. By Regional 19.3.2. By Product 19.3.3. By Application 19.3.4. By Molecule Type 19.3.5. By Route of Administration 19.3.6. By Distribution Channel 20. Competition Analysis 20.1. Competition Deep Dive 20.1.1. Pfizer Inc. 20.1.1.1. Overview 20.1.1.2. Product Portfolio 20.1.1.3. Profitability by Market Segments 20.1.1.4. Sales Footprint 20.1.1.5. Strategy Overview 20.1.1.5.1. Marketing Strategy 20.1.1.5.2. Product Strategy 20.1.1.5.3. Channel Strategy 20.1.2. Teva Pharmaceutical Industries Ltd. 20.1.2.1. Overview 20.1.2.2. Product Portfolio 20.1.2.3. Profitability by Market Segments 20.1.2.4. Sales Footprint 20.1.2.5. Strategy Overview 20.1.2.5.1. Marketing Strategy 20.1.2.5.2. Product Strategy 20.1.2.5.3. Channel Strategy 20.1.3. Sanofi S.A. 20.1.3.1. Overview 20.1.3.2. Product Portfolio 20.1.3.3. Profitability by Market Segments 20.1.3.4. Sales Footprint 20.1.3.5. Strategy Overview 20.1.3.5.1. Marketing Strategy 20.1.3.5.2. Product Strategy 20.1.3.5.3. Channel Strategy 20.1.4. Sun Pharmaceutical Industries Ltd. 20.1.4.1. Overview 20.1.4.2. Product Portfolio 20.1.4.3. Profitability by Market Segments 20.1.4.4. Sales Footprint 20.1.4.5. Strategy Overview 20.1.4.5.1. Marketing Strategy 20.1.4.5.2. Product Strategy 20.1.4.5.3. Channel Strategy 20.1.5. AstraZeneca Plc 20.1.5.1. Overview 20.1.5.2. Product Portfolio 20.1.5.3. Profitability by Market Segments 20.1.5.4. Sales Footprint 20.1.5.5. Strategy Overview 20.1.5.5.1. Marketing Strategy 20.1.5.5.2. Product Strategy 20.1.5.5.3. Channel Strategy 20.1.6. Merck & Co., Inc. 20.1.6.1. Overview 20.1.6.2. Product Portfolio 20.1.6.3. Profitability by Market Segments 20.1.6.4. Sales Footprint 20.1.6.5. Strategy Overview 20.1.6.5.1. Marketing Strategy 20.1.6.5.2. Product Strategy 20.1.6.5.3. Channel Strategy 20.1.7. Viatris + Mylan N.V 20.1.7.1. Overview 20.1.7.2. Product Portfolio 20.1.7.3. Profitability by Market Segments 20.1.7.4. Sales Footprint 20.1.7.5. Strategy Overview 20.1.7.5.1. Marketing Strategy 20.1.7.5.2. Product Strategy 20.1.7.5.3. Channel Strategy 20.1.8. Cipla Inc. 20.1.8.1. Overview 20.1.8.2. Product Portfolio 20.1.8.3. Profitability by Market Segments 20.1.8.4. Sales Footprint 20.1.8.5. Strategy Overview 20.1.8.5.1. Marketing Strategy 20.1.8.5.2. Product Strategy 20.1.8.5.3. Channel Strategy 20.1.9. Dr Reddy’s Laboratories Ltd. 20.1.9.1. Overview 20.1.9.2. Product Portfolio 20.1.9.3. Profitability by Market Segments 20.1.9.4. Sales Footprint 20.1.9.5. Strategy Overview 20.1.9.5.1. Marketing Strategy 20.1.9.5.2. Product Strategy 20.1.9.5.3. Channel Strategy 20.1.10. Samsung Biologics 20.1.10.1. Overview 20.1.10.2. Product Portfolio 20.1.10.3. Profitability by Market Segments 20.1.10.4. Sales Footprint 20.1.10.5. Strategy Overview 20.1.10.5.1. Marketing Strategy 20.1.10.5.2. Product Strategy 20.1.10.5.3. Channel Strategy 20.1.11. Abbott Laboratories 20.1.11.1. Overview 20.1.11.2. Product Portfolio 20.1.11.3. Profitability by Market Segments 20.1.11.4. Sales Footprint 20.1.11.5. Strategy Overview 20.1.11.5.1. Marketing Strategy 20.1.11.5.2. Product Strategy 20.1.11.5.3. Channel Strategy 21. Assumptions & Acronyms Used 22. Research Methodology
Explore Healthcare Insights
View Reports
Injectable Drug Market
